Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New dipeptidyl peptidase 4 inhibitors patented by Chinese company

Dec. 21, 2011

FDA does not require REMS program for Korlym in Cushing's syndrome

Dec. 20, 2011

Isis Pharmaceuticals provides update on NDA submission for mipomersen sodium

Dec. 19, 2011

Array BioPharma patents new GPR119 receptor agonists

Dec. 19, 2011

Novel PRCP inhibitors discovered at Merck & Co.

Dec. 19, 2011

BioSante Pharmaceuticals reports new phase III LibiGel data

Dec. 19, 2011

Catabasis raises additional funding for CAT-2003 development in hypertriglyceridemia

Dec. 16, 2011

AVL-292 may alleviate myeloma-related bone disease

Dec. 16, 2011

Bayer HealthCare submits applications for long-term contraceptive system

Dec. 15, 2011

Simcere and Bristol-Myers Squibb extend partnership

Dec. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...